TurnerTrends Stock Rating Report for BIIB
Data valid for week beginning July 21, 2008
|
BIIB [News]
|
Biogen Idec Inc
|
Company Profile
"Biogen Idec, Inc. engages in the development, manufacture, and commercialization of novel therapies primarily in the areas of oncology, neurology, immunology, and cardiology in the United States and internationally. Its products include AVONEX for the treatment of relapsing forms of multiple sclerosis (MS)- RITUXAN for the treatment of relapsed or refractory low-grade or follicular, CD20-positive, B-cell non-Hodgkin's lymphomas, or B-cell NHLs- TYSABRI for the treatment of relapsing forms of MS- and FUMADERM, an immunomodulator for the treatment of severe psoriasis. The company's other products under development include BG-12, a Phase III clinical trial product for the treatment of MS- Anti-CD80 MAb-galiximab, a Phase III clinical product for relapsed or refractory NHL- Anti-CD23 MAb-lumiliximab, a Phase II-III clinical product for the treatment of relapsed or refractory chronic lymphocytic leukemia- Humanized Anti-CD20 MAb-Ocrelizumab, a Phase III clinical product for the treatment of Rheumatoid Arthritis- and Lixivaptan, a Phase III clinical drug for the treatment of Acute Hyponatremia. In addition, its preclinical stage products include Volociximab, CNF2024, Natalizumab, RAF (BIIB024), CNF3647, Anti CRIPTO, Anti IGF-1R, Daclizumab, CDP-323, BIIB014, Neublastin, Baminercept-alfa, Anti-TWEAK, anti-CD40L Fab, ADENTRI, Aviptadil, and Long acting rFactor IX. Biogen Idec has collaboration agreements with PDL BioPharma, Inc.- Sunesis Pharmaceuticals, Inc.- Vernalis plc- Vetter Pharma-Fertigung GmbH & Co. KG- Elan Corporation plc- Alnylam Pharmaceuticals, Inc.- UCB SA- Neurimmune SubOne AG- Cardiokine Biopharma LLC- and Schering AG. The company was founded in 1985 and is based in Cambridge, Massachusetts."
|
Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.
|
|
|
Want to take a more "hands off" approach to investing with TurnerTrends? Try our managed accounts and hedge fund at Sabinal Capital Investments
|
|
Latest News
| Wed, 23 Jul 2008 17:53:00 Etc/GMT | [$$] Biogen Idec Gets Some Breathing Room (at Barron's Online) | | Wed, 23 Jul 2008 15:23:53 Etc/GMT | Icahn's Spotty Track Record (at Motley Fool) | | Wed, 23 Jul 2008 15:05:33 Etc/GMT | Analysts' Upgrades, Downgrades: Biogen (at TheStreet.com) | | Wed, 23 Jul 2008 13:39:52 Etc/GMT | New Star Analyst Rankings for BIOGEN IDEC INC (StarMine) | | Wed, 23 Jul 2008 10:59:54 Etc/GMT | What Now, Genentech Investors? (at TheStreet.com) | | Wed, 23 Jul 2008 01:48:16 Etc/GMT | Biogen IDEC, Inc. Q2 2008 Earnings Call Transcript (at Seeking Alpha) | | Tue, 22 Jul 2008 21:44:34 Etc/GMT | Health Winners & Losers: Biogen (at TheStreet.com) | | Tue, 22 Jul 2008 20:55:17 Etc/GMT | Biogen Idec's 2Q profit rises 11 percent (AP) | | Tue, 22 Jul 2008 18:00:09 Etc/GMT | The Next Home Run Stock (at Motley Fool) | | Tue, 22 Jul 2008 16:03:00 Etc/GMT | Biogen's 2nd-quarter earnings buoyed by strong MS-drug sales (at MarketWatch) | | Tue, 22 Jul 2008 15:42:45 Etc/GMT | Summary Box: Biogen Idec earnings (AP) | | Tue, 22 Jul 2008 14:31:21 Etc/GMT | Earnings roundup: DuPont, Biogen Idec (AP) | | Tue, 22 Jul 2008 14:24:00 Etc/GMT | Biotech Stocks: Merck, Schering-Plough hammered for second day (at MarketWatch) | | Tue, 22 Jul 2008 14:21:07 Etc/GMT | Outlook roundup: Avery Dennison, Biogen Idec (AP) | | Tue, 22 Jul 2008 14:09:55 Etc/GMT | Biogen Beats Estimates, Raises Guidance (at TheStreet.com) | | Tue, 22 Jul 2008 13:45:00 Etc/GMT | Strong MS drug sales buoy Biogen's earnings (at MarketWatch) | | Tue, 22 Jul 2008 13:08:29 Etc/GMT | Biogen Idec raises 2008 outlook on drug sales (AP) | | Tue, 22 Jul 2008 12:30:00 Etc/GMT | Biogen Idec Inc. Earnings Call scheduled for 8:30 am ET today (CCBN) | | Tue, 22 Jul 2008 12:11:00 Etc/GMT | [$$] Drug Sales Boost Biogen's Net (at The Wall Street Journal Online) | | Tue, 22 Jul 2008 11:52:09 Etc/GMT | Biogen second-quarter profit rises 11 percent (Reuters) | News provided by Yahoo! Finance |
|
